Human CD3 epsilon Antibody | R&D Systems MAB100-100 product information

product summary

company name :

R&D Systems

product type :

antibody

product name :

Human CD3 epsilon Antibody

catalog :

MAB100-100

quantity :

100 ug (also 25 ug, 500 ug)

price :

469 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

UCHT1

reactivity :

human, mouse

application :

western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section

more info or order :

R&D Systems product webpage

citations: 70

Reference
Manesia J, Maganti H, Almoflehi S, Jahan S, Hasan T, Pasha R, et al. AA2P-mediated DNA demethylation synergizes with stem cell agonists to promote expansion of hematopoietic stem cells. Cell Rep Methods. 2023;3:100663 pubmed publisher
Popugailo A, Rotfogel Z, Levy M, Turgeman O, Hillman D, Levy R, et al. The homodimer interfaces of costimulatory receptors B7 and CD28 control their engagement and pro-inflammatory signaling. J Biomed Sci. 2023;30:49 pubmed publisher
Liu S, Zhang Q, Zhang M, Zhong X, Wang W, Wang L, et al. Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis. Biomol Biomed. 2023;23:248-258 pubmed publisher
Peruzzu D, Dupuis M, Pierdominici M, Fecchi K, Gagliardi M, Ortona E, et al. Anti-Inflammatory Effects of 1,25(OH)2D/Calcitriol in T Cell Immunity: Does Sex Make a Difference?. Int J Mol Sci. 2022;23: pubmed publisher
Yang L, Liu S, Zhang Q, Jia S, Qiu C, Jin Z. Overexpression of ascitic interleukin-35 induces CD8+ T cell exhaustion in liver cirrhotic patients with spontaneous bacterial peritonitis. Int Immunopharmacol. 2022;108:108729 pubmed publisher
Aschmoneit N, Kocher K, Siegemund M, Lutz M, Kühl L, Seifert O, et al. Fc-based Duokines: dual-acting costimulatory molecules comprising TNFSF ligands in the single-chain format fused to a heterodimerizing Fc (scDk-Fc). Oncoimmunology. 2022;11:2028961 pubmed publisher
Gopalakrishnan R, Aid M, Mercado N, Davis C, Malik S, Geiger E, et al. Increased IL-6 expression precedes reliable viral detection in the rhesus macaque brain during acute SIV infection. JCI Insight. 2021;6: pubmed publisher
Li D, Bradley T, Cain D, Pedroza Pacheco I, Aggelakopoulou M, Parks R, et al. RAB11FIP5-Deficient Mice Exhibit Cytokine-Related Transcriptomic Signatures. Immunohorizons. 2020;4:713-728 pubmed publisher
Jiang X, Li X, Zheng S, Du G, Ma J, Zhang L, et al. Comparison study of different indoleamine-2,3 dioxygenase inhibitors from the perspective of pharmacodynamic effects. Int J Immunopathol Pharmacol. 2020;34:2058738420950584 pubmed publisher
Sapski S, Beha N, Kontermann R, M xfc ller D. Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response. Cancer Immunol Immunother. 2020;69:2291-2303 pubmed publisher
Cav xe9 M, Maillard S, Hildenbrand K, Mamelonet C, Feige M, Devergne O. Glycosaminoglycans bind human IL-27 and regulate its activity. Eur J Immunol. 2020;50:1484-1499 pubmed publisher
Huetter J, Gritzan U, Gutcher I, Doecke W, Luetke Eversloh M, Golfier S, et al. Characterization of BAY 1905254, an Immune Checkpoint Inhibitor Targeting the Immunoglobulin-Like Domain Containing Receptor 2 (ILDR2). Cancer Immunol Res. 2020;8:895-911 pubmed publisher
Tiirikainen M, Woetmann A, Norsgaard H, Santamaria Babi L, Lovato P. Ex vivo culture of lesional psoriasis skin for pharmacological testing. J Dermatol Sci. 2020;97:109-116 pubmed publisher
Chamcheu J, Esnault S, Adhami V, Noll A, Banang Mbeumi S, Roy T, et al. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. Cells. 2019;8: pubmed publisher
Zhou N, Wang K, Fu Z. Effect of morphine and a low dose of ketamine on the T cells of patients with refractory cancer pain in vitro. Oncol Lett. 2019;18:4230-4236 pubmed publisher
Dragovich M, Adam K, Strazza M, Tocheva A, Peled M, Mor A. SLAMF6 clustering is required to augment T cell activation. PLoS ONE. 2019;14:e0218109 pubmed publisher
Beha N, Harder M, Ring S, Kontermann R, Muller D. IL-15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands in the single-chain format for cancer immunotherapy. Mol Cancer Ther. 2019;: pubmed publisher
Bensch F, van der Veen E, Lub de Hooge M, Jorritsma Smit A, Boellaard R, Kok I, et al. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nat Med. 2018;24:1852-1858 pubmed publisher
Fellermeier Kopf S, Gieseke F, Sahin U, Muller D, Pfizenmaier K, Kontermann R. Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans. Oncoimmunology. 2018;7:e1471442 pubmed publisher
Nissen S, Pedersen J, Helleberg M, Kjær K, Thavachelvam K, Obel N, et al. Multiple Homozygous Variants in the STING-Encoding TMEM173 Gene in HIV Long-Term Nonprogressors. J Immunol. 2018;200:3372-3382 pubmed publisher
Ji W, Chen J, Mi Y, Wang G, Xu X, WANG W. Role of natural killer cells in liver transplantation treatment of liver cancer. Exp Ther Med. 2017;14:2380-2384 pubmed publisher
Fischer R, Marsal J, Guttà C, Eisler S, Peters N, Bethea J, et al. Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2. Sci Rep. 2017;7:6607 pubmed publisher
Yu B, Wang J, He C, Wang W, Tang J, Zheng R, et al. Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer. Exp Ther Med. 2017;14:831-840 pubmed publisher
Caer C, Rouault C, Le Roy T, Poitou C, Aron Wisnewsky J, Torcivia A, et al. Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Sci Rep. 2017;7:3000 pubmed publisher
Nakachi S, Sumitomo S, Tsuchida Y, Tsuchiya H, Kono M, Kato R, et al. Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis. Arthritis Res Ther. 2017;19:97 pubmed publisher
Tao C, Shao H, Zhang W, Bo H, Wu F, Shen H, et al. ??TCR immunoglobulin constant region domain exchange in human ??TCRs improves TCR pairing without altering TCR gene-modified T cell function. Mol Med Rep. 2017;15:1555-1564 pubmed publisher
Strazza M, Azoulay Alfaguter I, Peled M, Smrcka A, Skolnik E, Srivastava S, et al. PLCÎµ1 regulates SDF-1Î±-induced lymphocyte adhesion and migration to sites of inflammation. Proc Natl Acad Sci U S A. 2017;114:2693-2698 pubmed publisher
Yuan Y, Zhou C, Yuan J, Liu L, Guo X, Wang X, et al. NaHCO3 enhances the antitumor activities of cytokine-induced killer cells against hepatocellular carcinoma HepG2 cells. Oncol Lett. 2016;12:3167-3174 pubmed
Junker S, Frommer K, Krumbholz G, Tsiklauri L, Gerstberger R, Rehart S, et al. Expression of adipokines in osteoarthritis osteophytes and their effect on osteoblasts. Matrix Biol. 2017;62:75-91 pubmed publisher
Bredo G, Storie J, Shrestha Palikhe N, Davidson C, Adams A, Vliagoftis H, et al. Interleukin-25 initiates Th2 differentiation of human CD4(+) T cells and influences expression of its own receptor. Immun Inflamm Dis. 2015;3:455-68 pubmed publisher
Qu D, Sun J, Zhao L, Wang Q, Shao Q, Kong B, et al. Human trophoblast cells induced MDSCs from peripheral blood CD14(+) myelomonocytic cells via elevated levels of CCL2. Cell Mol Immunol. 2016;13:615-27 pubmed publisher
Huang W, Lu C, Wu Y, Ouyang S, Chen Y. T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines. J Exp Clin Cancer Res. 2015;34:54 pubmed publisher
Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell L, et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun. 2015;6:6692 pubmed publisher
Moore C, Cui Q, Warsi N, Durafourt B, Zorko N, Owen D, et al. Direct and indirect effects of immune and central nervous system-resident cells on human oligodendrocyte progenitor cell differentiation. J Immunol. 2015;194:761-72 pubmed publisher
Van Belle T, Vanherwegen A, Feyaerts D, De Clercq P, Verstuyf A, Korf H, et al. 1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patients. PLoS ONE. 2014;9:e109194 pubmed publisher
Fan M, Zhang Y, Huang Z, Liu J, Guo X, Zhang H, et al. Optimizations of siRNA design for the activation of gene transcription by targeting the TATA-box motif. PLoS ONE. 2014;9:e108253 pubmed publisher
Zhu L, Huang Z, Stålesen R, Hansson G, Li N. Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T-cell proliferation. J Thromb Haemost. 2014;12:1156-65 pubmed publisher
Gao D, Li C, Xie X, Zhao P, Wei X, Sun W, et al. Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients. PLoS ONE. 2014;9:e93886 pubmed publisher
Ruan M, Thorn K, Liu S, Li S, Yang W, Zhang C, et al. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma. Int J Oncol. 2014;44:2103-10 pubmed publisher
Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M, et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 2014;14:342-56 pubmed publisher
Sgarbanti M, Marsili G, Remoli A, Stellacci E, Mai A, Rotili D, et al. I?B kinase ? targets interferon regulatory factor 1 in activated T lymphocytes. Mol Cell Biol. 2014;34:1054-65 pubmed publisher
Renand A, Milpied P, Rossignol J, Bruneau J, Lemonnier F, Dussiot M, et al. Neuropilin-1 expression characterizes T follicular helper (Tfh) cells activated during B cell differentiation in human secondary lymphoid organs. PLoS ONE. 2013;8:e85589 pubmed publisher
Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. J Allergy Clin Immunol. 2014;133:448-60 pubmed publisher
Wang F, Xu Z, Zhou J, Lo W, Lau C, Nangle L, et al. Regulated capture by exosomes of mRNAs for cytoplasmic tRNA synthetases. J Biol Chem. 2013;288:29223-8 pubmed publisher
Ramgolam V, Sha Y, Marcus K, Choudhary N, Troiani L, Chopra M, et al. B cells as a therapeutic target for IFN-? in relapsing-remitting multiple sclerosis. J Immunol. 2011;186:4518-26 pubmed publisher
Eikawa S, Ohue Y, Kitaoka K, Aji T, Uenaka A, Oka M, et al. Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6. J Immunol. 2010;185:6734-40 pubmed publisher
Jones G, Stumhofer J, Foster T, Twohig J, Hertzog P, Topley N, et al. Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. FASEB J. 2011;25:409-19 pubmed publisher
Pennino D, Eyerich K, Scarponi C, Carbone T, Eyerich S, Nasorri F, et al. IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol. 2010;184:4880-8 pubmed publisher
Elmarghani A, Abuabaid H, Kjellen P. TOM1L is involved in a novel signaling pathway important for the IL-2 production in Jurkat T cells stimulated by CD3/CD28 co-ligation. Mediators Inflamm. 2009;2009:416298 pubmed publisher
Witte K, Gruetz G, Volk H, Looman A, Asadullah K, Sterry W, et al. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun. 2009;10:702-14 pubmed publisher
Ni Z, Walcheck B. Cutaneous lymphocyte-associated antigen (CLA) T cells up-regulate P-selectin ligand expression upon their activation. Clin Immunol. 2009;133:257-64 pubmed publisher
Longo O, Tripiciano A, Fiorelli V, Bellino S, Scoglio A, Collacchi B, et al. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Vaccine. 2009;27:3306-12 pubmed publisher
Lundqvist A, Yokoyama H, Smith A, Berg M, Childs R. Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells. Blood. 2009;113:6120-7 pubmed publisher
Hirosako S, Goto E, Fujii K, Tsumori K, Hirata N, Tsumura S, et al. Human bronchial intraepithelial T cells produce interferon-gamma and stimulate epithelial cells. Clin Exp Immunol. 2009;155:266-74 pubmed publisher
Tran C, Thacker S, Louie D, Oliver J, White P, Endres J, et al. Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3. J Immunol. 2008;180:2989-98 pubmed
McFadden C, Morgan R, Rahangdale S, Green D, Yamasaki H, Center D, et al. Preferential migration of T regulatory cells induced by IL-16. J Immunol. 2007;179:6439-45 pubmed
Rossol M, Meusch U, Pierer M, Kaltenhäuser S, Hantzschel H, Hauschildt S, et al. Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells. J Immunol. 2007;179:4239-48 pubmed
Stebbings R, Findlay L, Edwards C, Eastwood D, Bird C, North D, et al. "Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol. 2007;179:3325-31 pubmed
Bayry J, Triebel F, Kaveri S, Tough D. Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells. J Immunol. 2007;178:4184-93 pubmed
Mamoni R, Blotta M. Flow-cytometric analysis of cytokine production in human paracoccidioidomycosis. Cytokine. 2006;35:207-16 pubmed
Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux N, et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol. 2006;169:987-98 pubmed
Markovic S, Nevala W, Uhl C, Celis E, McKean D. A reproducible method for the enumeration of functional (cytokine producing) versus non-functional peptide-specific cytotoxic T lymphocytes in human peripheral blood. Clin Exp Immunol. 2006;145:438-47 pubmed
Ren Y, Lin C, Li Z, Chen X, Huang X, Lui V, et al. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology. 2005;46:659-67 pubmed
Ogilvie R, Abelson M, Hau H, Vlasova I, Blackshear P, Bohjanen P. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J Immunol. 2005;174:953-61 pubmed
Liao T, Yurgelun M, Chang S, Zhang H, Murakami K, Blaine T, et al. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J Orthop Res. 2005;23:203-9 pubmed
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241-54 pubmed
Wang P, Zhang J, Bian H, Wu P, Kuvelkar R, Kung T, et al. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. Biochem J. 2004;380:425-33 pubmed
Janardhan A, Swigut T, Hill B, Myers M, Skowronski J. HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis. PLoS Biol. 2004;2:E6 pubmed
Takahashi R, Mizukawa Y, Yamazaki Y, Hayakawa K, Hayakawa J, Kudo A, et al. In vitro differentiation from naive to mature E-selectin binding CD4 T cells: acquisition of skin-homing properties occurs independently of cutaneous lymphocyte antigen expression. J Immunol. 2003;171:5769-77 pubmed
Han M, Kim J, Park B, Kim J, Hwang B, Lee H, et al. NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis. J Leukoc Biol. 2003;73:525-9 pubmed

product information

brand :

R&D Systems

master code :

MAB100

SKU :

MAB100-100

product name :

Human CD3 epsilon Antibody

unit size :

100 ug (also 25 ug, 500 ug)

seo description :

The Human CD3 epsilon Antibody from R&D Systems is a mouse monoclonal antibody to CD3 epsilon. This antibody reacts with feline,human,mouse,primate. The Human CD3 epsilon Antibody has been validated for the following applications: Immunocytochemistry,Bioassay,Binding Assay,ELISA Development,Stimulation,T Cell Activation,Tissue Culture,Flow Cytometry,Immunoprecipitation,Functional Assay,Cell Culture,Immunohistochemistry,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Western Blot,T Cell Stimulation,CyTOF-reported.

target :

CD3 epsilon

category :

Primary Antibodies

buffer :

Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.

clonality :

Monoclonal

clone :

UCHT1

conjugate :

Unconjugated

dilution :

Western Blot 2 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Immunoprecipitation, T Cell Stimulation, Immunocytochemistry 8-25 ug/mL, CyTOF-reported

host :

Mouse

immunogen :

Human thymocytes (1),

isotype :

IgG1

purity :

Protein A or G purified from hybridoma culture supernatant

species :

Feline,Human,Mouse,Primate

specificity :

Recognizes the epsilon -chain of the CD3/T cell antigen receptor complex (McMichael, A.J. et al . (1987) Leucocyte Typing III: White Cell Differentiation Antigens, Oxford University Press, New York; Knapp, W. et al . (1989) Leucocyte Typing IV: White Cell Differentiation Antigens, Oxford University Press, New York; Schlossman, S. et al . (1995) Leucocyte Typing V: White Cell Differentiation Antigens, Oxford University Press, New York).

gene symbol :

CD3E

endotoxin note :

<0.10 EU per 1 ╡g of the antibody by the LAL method.

top caption :

CD3e antibody in Human PBMCs by Immunocytochemistry (ICC).

applications :

Western Blot,T Cell Stimulation,CyTOF-reported,Bioassay,Binding Assay,ELISA Development,Stimulation,T Cell Activation,Tissue Culture,Flow Cytometry,Immunohistochemistry,Immunoprecipitation,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,Immunocytochemistry,Functional Assay,Cell Culture

extended description :

Clone UCHT1 was used by HLDA to establish CD designation

USD :

469 USD

product details :

Clone UCHT1 was used by HLDA to establish CD designation

alt names :

CD3e, CD3e antigen, CD3e antigen, epsilon polypeptide (TiT3 complex), CD3e molecule, epsilon (CD3-TCR complex), CD3-epsilon, FLJ18683, T3E, T-cell antigen receptor complex, epsilon subunit of T3, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, TCRE

storage :

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.

more info or order :

R&D Systems product webpage